The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazid.

Clin Microbiol Infect

Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; TB Center Beatrixoord, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address:

Published: August 2022

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.cmi.2022.03.033	DOI Listing

Publication Analysis

case expanding

expanding worldwide

worldwide access

access point

point care

care molecular

molecular drug

drug susceptibility

susceptibility testing

testing isoniazid

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!